(Q38103493)

28 August 2017

title

The role of inflammatory cytokines on the aetiopathogenesis of depression (English)

1 reference

28 August 2017

Karan Makhija

1

1 reference

28 August 2017

Satish Karunakaran

series ordinal

2

1 reference

28 August 2017

language of work or name

1 reference

1 May 2013

1 reference

Australian and New Zealand Journal of Psychiatry

28 August 2017

published in

1 reference

28 August 2017

volume

47

1 reference

28 August 2017

issue

9

1 reference

28 August 2017

page(s)

828-839

1 reference

Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

An open label trial of C-1073 (mifepristone) for psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

A mechanism converting psychosocial stress into mononuclear cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The role of immune genes in the association between depression and inflammation: a review of recent clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Immune system to brain signaling: neuropsychopharmacological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The dexamethasone suppression test for melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Depression and hippocampal neurogenesis: a road to remission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Contextual fear, gestalt memories, and the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Fish consumption and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Interleukin-1 beta -511C/T genetic polymorphism is associated with age of onset of geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Depression: an inflammatory illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Stress and depression: possible links to neuron death in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Course of illness, hippocampal function, and hippocampal volume in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

A review on the acute phase response in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Evidence for an immune response in major depression: a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Lower serum vitamin E concentrations in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Neuropsychiatric disorders related to interferon and interleukins treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Antioxidant enzyme activities and oxidative stress in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Cytokines and glucocorticoid receptor signaling. Relevance to major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Inflammation and depression: why poststroke depression may be the norm and not the exception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Is depression an inflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Functional biomarkers of depression: diagnosis, treatment, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Indicators of immune activation in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The macrophage theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Serotonin transporter gene, depressive symptoms, and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

The fibroblast growth factor system and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

Glucocorticoids, cytokines and brain abnormalities in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867413488220

21 January 2018

Identifiers

DOI

10.1177/0004867413488220

1 reference

28 August 2017

1 reference